THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)

Trial Profile

THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)

Recruiting
Phase of Trial: Phase III

Latest Information Update: 04 Nov 2017

At a glance

  • Drugs Alteplase (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Acronyms THAWS
  • Most Recent Events

    • 01 Nov 2017 Planned end date changed to 31 Mar 2020.
    • 05 Apr 2017 Planned End Date changed from 1 Mar 2018 to 1 Mar 2020.
    • 05 Apr 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top